| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CTI BIOPHARMA CORP | EVP & Chief Commercial Officer | Common Stock | 0 | $9.10 | 26 Jun 2023 | Direct | |
| CTI BIOPHARMA CORP | EVP & Chief Commercial Officer | Stock Option (Right to Buy) | 0 | 26 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924323016479-fong-james-k-2023-06-26 | CTI BIOPHARMA CORP | 26 Jun 2023 | 10 | -$32,442 | 4 | EVP & Chief Commercial Officer | 26 Jun 2023, 16:05 |
| /report/000089924323008750-fong-james-k-2023-03-14 | CTI BIOPHARMA CORP | 14 Mar 2023 | 1 | $0 | 4 | EVP & Chief Commercial Officer | 16 Mar 2023, 17:52 |
| /report/000089129323000003-fong-james-k-2023-01-24 | CTI BIOPHARMA CORP | 24 Jan 2023 | 4 | -$505,110 | 4 | EVP & Chief Commercial Officer | 26 Jan 2023, 15:49 |
| /report/000089924322010765-fong-james-k-2022-02-28 | CTI BIOPHARMA CORP | 28 Feb 2022 | 0 | $0 | 3 | Senior Vice President and Chief Commercial Officer Exhibit 24 - Power of Attorney | 11 Mar 2022, 18:37 |